Navina, a Tel Aviv, Israel-based developer of AI-powered clinical platform for primary care, secured $15m in Series A funding.
The round, which brought total funding to date to $22m, was led by Vertex Ventures Israel with participation from Schusterman Family Investments (SFI) and existing investor Grove Ventures.
The company intends to use the funds to accelerate investment in its AI technology, and expand within physician groups and the enterprise healthcare market.
Led by Ronen Lavi, co-founder and CEO, Navina uses medically-informed AI to replace disorganized patient data with an intuitive Patient Portrait – a logical grid that makes it possible for every primary care physician to assess even the most complex cases in minutes. The platform has already demonstrated measurable clinical and economic impact for multi-specialty and primary care physician groups nationwide. Since adopting the system, groups are seeing increases in HCC-RAF (Risk Adjustment Factor) scores, which translates into revenue.
FinSMEs
19/10/2021